HOXA9
MOLECULAR TARGEThomeobox A9
HOXA9 (homeobox A9) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting HOXA9
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Adenosine | 0.69 | 1 |
| 2 | Ampicillin Semi-synthetic derivative of penicillin that functions as | 0.69 | 1 |
| 3 | Equilin | 0.69 | 1 |
| 4 | Ethidium | 0.69 | 1 |
| 5 | felbinac | 0.69 | 1 |
| 6 | Fusaric Acid | 0.69 | 1 |
| 7 | gamma-Linolenic Acid | 0.69 | 1 |
| 8 | Harmaline | 0.69 | 1 |
| 9 | p-Aminohippuric Acid | 0.69 | 1 |
| 10 | Temozolomide | 0.69 | 1 |
| 11 | Trifluridine | 0.69 | 1 |
About HOXA9 as a Drug Target
HOXA9 (homeobox A9) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented HOXA9 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
HOXA9 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.